Abiopharma

🔍 Renz Justin A (Executive)

Company: ZEVRA THERAPEUTICS, INC. (ZVRA)

Report Date: 2026-03-18

Detailed Transactions and Holdings:

• Acquired 300,000 shares of Stock Option (right to buy) at $9.55 per share (Derivative)
  Date: 2026-03-18 | Code: A | Expires: 2036-03-17 | equity_swap_involved: 0 | shares_owned_after: 300,000.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, March 18, 2026.
• F2: Grant to the Reporting Person of a stock option under the Issuer's 2023 Employment Inducement Award Plan. The option will vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued service on such vesting date. All shares underlying the option will vest in full and become exercisable immediately prior to a change of control of the Issuer. Vesting of the option will be accelerated by 12 months if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.